Valuation (16%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -4.30 | N/A |
PEG Ratio (TTM) | 1.97 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 10.95 | N/A |
P/FCF Ratio (TTM) | -6.98 | N/A |
Price to 5YR AVG Earnings Ratio | -4.74 | N/A |
Price to 5YR AVG FCF Ratio | -14.49 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -157.55% | N/A |
ROE (TTM) | -225.12% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | -175.02% | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -13.59% | -3.57% | -13.84% |
Revenue | N/A | N/A | -20.00% |
Net Income | -23.35% | -0.87% | -28.18% |
Cash Flow | -14.55% | -34.51% | -43.82% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.89 | N/A |
Quick Ratio (TTM) | 2.93 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 3.73 | N/A |
LTL to 5YR AVG FCF | -0.11 | N/A |
Shares Outstanding Growth 5YR AVG | 11.58% | N/A |